Twist Bioscience Corp (TWST) is ready for next Episode as it posted an annual sales of 245,110 K

Twist Bioscience Corp (NASDAQ: TWST) on Friday, plunged -19.00% from the previous trading day, before settling in for the closing price of $53.05. Within the past 52 weeks, TWST’s price has moved between $14.42 and $60.90.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 60.13% over the past five years. The company achieved an average annual earnings per share of 6.04%. With a float of $55.73 million, this company’s outstanding shares have now reached $57.56 million.

Let’s look at the performance matrix of the company that is accounted for 919 employees.

Twist Bioscience Corp (TWST) Insider Updates

Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Twist Bioscience Corp is 4.29%, while institutional ownership is 113.82%. The most recent insider transaction that took place on Aug 01 ’24, was worth 1,039,119. Before that another transaction happened on Jul 23 ’24, when Company’s President and COO sold 2,207 for $56.62, making the entire transaction worth $124,971. This insider now owns 171,212 shares in total.

Twist Bioscience Corp (TWST) Performance Highlights and Predictions

According to the Wall Street analysts, stocks earnings will be around 6.04% per share during the next fiscal year.

Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators

Twist Bioscience Corp (TWST) is currently performing well based on its current performance indicators. A quick ratio of 4.52 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.48.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.81, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -2.39 in one year’s time.

Technical Analysis of Twist Bioscience Corp (TWST)

Twist Bioscience Corp (NASDAQ: TWST) saw its 5-day average volume 1.51 million, a positive change from its year-to-date volume of 1.05 million. As of the previous 9 days, the stock’s Stochastic %D was 17.64%. Additionally, its Average True Range was 3.84.

During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 46.46%, which indicates a significant increase from 3.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 99.63% in the past 14 days, which was higher than the 77.07% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $50.30, while its 200-day Moving Average is $36.52. Nevertheless, the first resistance level for the watch stands at $47.47 in the near term. At $51.98, the stock is likely to face the second major resistance level. The third major resistance level sits at $54.56. If the price goes on to break the first support level at $40.39, it is likely to go to the next support level at $37.81. Assuming the price breaks the second support level, the third support level stands at $33.30.

Twist Bioscience Corp (NASDAQ: TWST) Key Stats

Market capitalization of the company is 2.50 billion based on 58,226K outstanding shares. Right now, sales total 245,110 K and income totals -204,620 K. The company made 75,300 K in profit during its latest quarter, and -45,490 K in sales during its previous quarter.